Literature DB >> 18039129

Autophagy: basic principles and relevance to disease.

Mondira Kundu1, Craig B Thompson.   

Abstract

Autophagy is a process by which cytoplasmic components are sequestered in double membrane vesicles and degraded upon fusion with lysosomal compartments. In yeast, autophagy is activated in response to changes in the extracellular milieu. Depending upon the stimulus, autophagy can degrade cytoplasmic contents nonspecifically or can target the degradation of specific cellular components. Both of these have been adopted in higher eukaryotes and account for the expanding role of autophagy in various cellular processes, as well as contribute to the variation in cellular outcomes after induction of autophagy. In some cases, autophagy appears to be an adaptive response, whereas under other circumstances it is involved in cell death. In mammals, autophagy has been implicated in either the pathogenesis or response to a wide variety of diseases, including neurodegenerative disease, chronic bacterial and viral infections, atherosclerosis, and cancer. As the basic molecular pathways that regulate autophagy are elucidated, the relationship of autophagy to the pathogenesis of various disease states emerges.

Entities:  

Mesh:

Year:  2008        PMID: 18039129     DOI: 10.1146/annurev.pathmechdis.2.010506.091842

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  220 in total

1.  Harnessing autophagy for adoptive T-cell therapy.

Authors:  Shoba Amarnath; Daniel H Fowler
Journal:  Immunotherapy       Date:  2012-01       Impact factor: 4.196

2.  Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.

Authors:  Catherine Meyer-Schwesinger; Tobias N Meyer; Henning Sievert; Elion Hoxha; Marlies Sachs; Eva-Maria Klupp; Silvia Münster; Stefan Balabanov; Lucie Carrier; Udo Helmchen; Friedrich Thaiss; Rolf A K Stahl
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 4.  HLA-B27 misfolding and ankylosing spondylitis.

Authors:  Robert A Colbert; Tri M Tran; Gerlinde Layh-Schmitt
Journal:  Mol Immunol       Date:  2013-08-30       Impact factor: 4.407

Review 5.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

6.  Autophagy modulates Borrelia burgdorferi-induced production of interleukin-1β (IL-1β).

Authors:  Kathrin Buffen; Marije Oosting; Svenja Mennens; Paras K Anand; Theo S Plantinga; Patrick Sturm; Frank L van de Veerdonk; Jos W M van der Meer; Ramnik J Xavier; Thirumala-Devi Kanneganti; Mihai G Netea; Leo A B Joosten
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

Review 7.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

8.  2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy.

Authors:  Wensi Song; Fan Wang; Parisa Lotfi; Marco Sardiello; Laura Segatori
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

9.  Autophagy Regulates Craniofacial Bone Acquisition.

Authors:  Neil Thomas; Han Kyoung Choi; Xiaoxi Wei; Li Wang; Yuji Mishina; Jun-Lin Guan; Fei Liu
Journal:  Calcif Tissue Int       Date:  2019-08-01       Impact factor: 4.333

10.  Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine.

Authors:  Daniela Laura Papademetrio; Victoria Cavaliere; Tania Simunovich; Susana Costantino; María Dolores Campos; Tomás Lombardo; Claudio Marcelo Fader Kaiser; Elida Alvarez
Journal:  Target Oncol       Date:  2013-04-16       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.